使用抗TNF-α治疗后中毒性表皮坏死松解症迅速消退。 - Suppr

Suppr

超能文献

Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment.

作者信息

Hunger Robert E, Hunziker Thomas, Buettiker Urs, Braathen Lasse R, Yawalkar Nikhil

出版信息

J Allergy Clin Immunol. 2005 Oct;116(4):923-4. doi: 10.1016/j.jaci.2005.06.029. Epub 2005 Aug 19.

DOI:10.1016/j.jaci.2005.06.029

PMID:16210071

Abstract

摘要

相似文献

Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment.

J Allergy Clin Immunol. 2005 Oct;116(4):923-4. doi: 10.1016/j.jaci.2005.06.029. Epub 2005 Aug 19.

Severe cutaneous adverse reactions to drugs.

Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):304-9. doi: 10.1097/ACI.0b013e328216f54a.

Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.

Acta Derm Venereol. 2008;88(4):420-1. doi: 10.2340/00015555-0462.

Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis.

Arch Dermatol. 1994 May;130(5):605-8.

Reaction to biological drugs: infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus.

Clin Exp Dermatol. 2012 Dec;37(8):879-81. doi: 10.1111/j.1365-2230.2012.04357.x. Epub 2012 Apr 30.

Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in mice.

Cancer Res. 2009 Jul 15;69(14):5643-7. doi: 10.1158/0008-5472.CAN-09-0487. Epub 2009 Jul 7.

[Drug induced toxic epidermal necrolysis].

Nihon Rinsho. 2004 May;62 Suppl 5:515-8.

[Exudative erythema multiforme with transition to a toxic epidermal necrolysis after taking aceclofenac (Beofenac)].

Dtsch Med Wochenschr. 2003 Mar 7;128(10):487-90. doi: 10.1055/s-2003-37627.

[Toxic epidermal necrolysis induced by NSAID].

Z Rheumatol. 2003 Oct;62(5):474-5. doi: 10.1007/s00393-003-0535-6.

A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin.

Photodermatol Photoimmunol Photomed. 2005 Apr;21(2):100-2. doi: 10.1111/j.1600-0781.2005.00149.x.

引用本文的文献

The case for etanercept in the management of toxic epidermal necrolysis.

Skin Health Dis. 2025 May 28;5(4):247-255. doi: 10.1093/skinhd/vzaf012. eCollection 2025 Aug.

Feedback regulation of VISTA and Treg by TNF-α controls T cell responses in drug allergy.

Allergy. 2025 May;80(5):1400-1416. doi: 10.1111/all.16393. Epub 2024 Nov 11.

Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy.

J Inflamm Res. 2024 Apr 17;17:2337-2351. doi: 10.2147/JIR.S454673. eCollection 2024.

Biologic TNF-α Inhibitors for Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis.

Dermatol Ther (Heidelb). 2023 Jun;13(6):1305-1327. doi: 10.1007/s13555-023-00928-w. Epub 2023 May 13.

A Review of the Systemic Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Biomedicines. 2022 Aug 28;10(9):2105. doi: 10.3390/biomedicines10092105.

Current Perspectives on Severe Drug Eruption.

Clin Rev Allergy Immunol. 2021 Dec;61(3):282-298. doi: 10.1007/s12016-021-08859-0. Epub 2021 Jul 17.

Indian J Crit Care Med. 2021 May;25(5):575-579. doi: 10.5005/jp-journals-10071-23826.

Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.

F1000Res. 2020 Jun 16;9. doi: 10.12688/f1000research.24748.1. eCollection 2020.

Stevens-Johnsons syndrome or drug-induced lupus - a clinical dilemma: A case report and review of the literature.

Biomed Rep. 2018 Jul;9(1):37-41. doi: 10.3892/br.2018.1098. Epub 2018 May 16.

Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!

Indian J Dermatol. 2018 Mar-Apr;63(2):117-124. doi: 10.4103/ijd.IJD_583_17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment.

作者信息

Hunger Robert E, Hunziker Thomas, Buettiker Urs, Braathen Lasse R, Yawalkar Nikhil

出版信息

J Allergy Clin Immunol. 2005 Oct;116(4):923-4. doi: 10.1016/j.jaci.2005.06.029. Epub 2005 Aug 19.

DOI:10.1016/j.jaci.2005.06.029

PMID:16210071

Abstract

摘要

相似文献

Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment.

J Allergy Clin Immunol. 2005 Oct;116(4):923-4. doi: 10.1016/j.jaci.2005.06.029. Epub 2005 Aug 19.

Severe cutaneous adverse reactions to drugs.

Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):304-9. doi: 10.1097/ACI.0b013e328216f54a.

Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.

Acta Derm Venereol. 2008;88(4):420-1. doi: 10.2340/00015555-0462.

Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis.

Arch Dermatol. 1994 May;130(5):605-8.

Reaction to biological drugs: infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus.

Clin Exp Dermatol. 2012 Dec;37(8):879-81. doi: 10.1111/j.1365-2230.2012.04357.x. Epub 2012 Apr 30.

Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in mice.

Cancer Res. 2009 Jul 15;69(14):5643-7. doi: 10.1158/0008-5472.CAN-09-0487. Epub 2009 Jul 7.

[Drug induced toxic epidermal necrolysis].

Nihon Rinsho. 2004 May;62 Suppl 5:515-8.

[Exudative erythema multiforme with transition to a toxic epidermal necrolysis after taking aceclofenac (Beofenac)].

Dtsch Med Wochenschr. 2003 Mar 7;128(10):487-90. doi: 10.1055/s-2003-37627.

[Toxic epidermal necrolysis induced by NSAID].

Z Rheumatol. 2003 Oct;62(5):474-5. doi: 10.1007/s00393-003-0535-6.

A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin.

Photodermatol Photoimmunol Photomed. 2005 Apr;21(2):100-2. doi: 10.1111/j.1600-0781.2005.00149.x.

引用本文的文献

The case for etanercept in the management of toxic epidermal necrolysis.

Skin Health Dis. 2025 May 28;5(4):247-255. doi: 10.1093/skinhd/vzaf012. eCollection 2025 Aug.

Feedback regulation of VISTA and Treg by TNF-α controls T cell responses in drug allergy.

Allergy. 2025 May;80(5):1400-1416. doi: 10.1111/all.16393. Epub 2024 Nov 11.

Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy.

J Inflamm Res. 2024 Apr 17;17:2337-2351. doi: 10.2147/JIR.S454673. eCollection 2024.

Biologic TNF-α Inhibitors for Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis.

Dermatol Ther (Heidelb). 2023 Jun;13(6):1305-1327. doi: 10.1007/s13555-023-00928-w. Epub 2023 May 13.

A Review of the Systemic Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Biomedicines. 2022 Aug 28;10(9):2105. doi: 10.3390/biomedicines10092105.

Current Perspectives on Severe Drug Eruption.

Clin Rev Allergy Immunol. 2021 Dec;61(3):282-298. doi: 10.1007/s12016-021-08859-0. Epub 2021 Jul 17.

Indian J Crit Care Med. 2021 May;25(5):575-579. doi: 10.5005/jp-journals-10071-23826.

Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.

F1000Res. 2020 Jun 16;9. doi: 10.12688/f1000research.24748.1. eCollection 2020.

Stevens-Johnsons syndrome or drug-induced lupus - a clinical dilemma: A case report and review of the literature.

Biomed Rep. 2018 Jul;9(1):37-41. doi: 10.3892/br.2018.1098. Epub 2018 May 16.

Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!

Indian J Dermatol. 2018 Mar-Apr;63(2):117-124. doi: 10.4103/ijd.IJD_583_17.